Jones Financial Companies’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.12M Buy
73,049
+69,996
+2,293% +$6.28M ﹤0.01% 1002
2025
Q4
$267K Buy
3,053
+420
+16% +$31.9K ﹤0.01% 1787
2025
Q3
$147K Buy
2,633
+547
+26% +$31.5K ﹤0.01% 1914
2025
Q2
$122K Buy
2,086
+1,550
+289% +$100K ﹤0.01% 1853
2025
Q1
$38.9K Buy
536
+284
+113% +$23.5K ﹤0.01% 2165
2024
Q4
$20.8K Buy
252
+11
+5% +$868 ﹤0.01% 2239
2024
Q3
$17K Buy
241
+75
+45% +$5.29K ﹤0.01% 2015
2024
Q2
$11.4K Buy
166
+136
+453% +$8.13K ﹤0.01% 1722
2024
Q1
$1.61K Sell
30
-120
-80% -$6.45K ﹤0.01% 1276
2023
Q4
$7.99K Hold
150
﹤0.01% 708
2023
Q3
$7.45K Buy
+150
New +$8.39K ﹤0.01% 499
2022
Q3
Sell
-14
Closed -$1K 608
2022
Q2
$1K Buy
+14
New +$920 ﹤0.01% 640

Other funds holding GMED

Jones Financial Companies's GMED Position: Q1 2026 in Review

Jones Financial Companies increased its Globus Medical (GMED) stake by 2,293% in Q1 2026, buying an estimated $6.28M and bringing the position to 73,049 shares worth $6.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1002.

Jones Financial Companies first reported a position in GMED in Q2 2022 and has held it in 12 quarters since. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Jones Financial Companies held 73,049 shares of Globus Medical worth $6.12M as of Q1 2026.
  • Jones Financial Companies bought 69,996 Globus Medical shares in Q1 2026, an estimated $6.28M.
  • Globus Medical made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #1002 holding.
  • Jones Financial Companies first reported a position in Globus Medical in Q2 2022 and has held it in 12 quarters since.
  • 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.